Rchr
J-GLOBAL ID:202101016755343770   Update date: Jul. 14, 2024

Hokuto Daisuke

ホクトウ ダイスケ | Hokuto Daisuke
Affiliation and department:
Research theme for competitive and other funds  (4):
  • 2019 - 2022 Development of a novel combination of tumor immunotherapy targeting the T-cell negative pathway and anti-tumor drugs
  • 2020 - 2021 消化器癌における静脈血栓塞栓症機序の新概念と次世代型抗血栓療法の開発
  • 2016 - 2019 Research of new immunotherapy for colorectal liver metastasis using T-cell negative pathway
  • 2012 - 2014 Research for realization of cancer therapy targeted for T cell negative pathway of hepatocellular carcinoma
Papers (148):
  • Hiroji Shinkawa, Masaki Kaibori, Daijiro Kabata, Takuya Nakai, Masaki Ueno, Daisuke Hokuto, Hisashi Ikoma, Hiroya Iida, Koji Komeda, Shogo Tanaka, et al. Laparoscopic and open minor liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a multicenter study using inverse probability weighting approach. Surgical endoscopy. 2023
  • Shunsuke Doi, Satoshi Yasuda, Daisuke Hokuto, Naoki Kamitani, Yasuko Matsuo, Takeshi Sakata, Satoshi Nishiwada, Minako Nagai, Kota Nakamura, Taichi Terai, et al. Impact of the Prolonged Intermittent Pringle Maneuver on Post-Hepatectomy Liver Failure: Comparison of Open and Laparoscopic Approaches. World journal of surgery. 2023
  • Yuki Imazu, Yasuko Matsuo, Daisuke Hokuto, Satoshi Yasuda, Takahiro Yoshikawa, Naoki Kamitani, Chieko Yoshida, Toshihide Sasaki, Masayuki Sho. Distinct role of tumor-infiltrating lymphocytes between synchronous and metachronous colorectal cancer. Langenbeck's archives of surgery. 2023. 408. 1. 72-72
  • Daisuke Hokuto, Satoshi Yasuda, Naoki Kamitani, Yasuko Matsuo, Shunsuke Doi, Masayuki Sho. Detailed analysis of recurrent sites after wedge resection for primary hepatocellular carcinoma considering the potential usefulness of anatomic resection: a retrospective cohort study. Langenbeck's archives of surgery. 2023. 408. 1. 29-29
  • Satoshi Yasuda, Daisuke Hokuto, Naoki Kamitani, Yasuko Matsuo, Shunsuke Doi, Kenji Nakagawa, Satoshi Nishiwada, Minako Nagai, Taichi Terai, Masayuki Sho. Pre- and postoperative C-reactive protein as a risk factor of organ/space surgical site infection after hepatectomy. Langenbeck's archives of surgery. 2023. 408. 1. 13-13
more...
MISC (6):
  • S. Kinoshita, M. Sho, A. Takahiro, T. Nomi, I. Yamato, D. Hokuto, S. Yasuda, Y. Nakajima. The Role of Gemcitabine/S-1 in the Neoadjuvant Setting for Locally Advanced Pancreatic Cancer. PANCREAS. 2012. 41. 7. 1157-1157
  • M. Sho, T. Tanaka, T. Akahori, S. Kinoshita, T. Yamada, T. Nomi, I. Yamato, D. Hokuto, C. Kawaguchi, S. Yasuda, et al. Novel Multimodal Treatment for Resectable Pancreatic Cancer. PANCREAS. 2012. 41. 7. 1162-1162
  • 童 仁, 庄 雅之, 野見 武男, 赤堀 宇広, 山戸 一郎, 北東 大督, 川口 千尋, 安田 里司, 木下 正一, 金廣 裕道, et al. この症例をどうするか「胆」 興味ある病態および治療経過を示した高ビリルビン血症の1例. 日本肝胆膵外科学会・学術集会プログラム・抄録集. 2012. 24回. 213-213
  • M. Sho, T. Tanaka, H. Kanehiro, S. Ko, T. Yamada, T. Nomi, T. Akahori, I. Yamato, D. Jin, D. Hokuto, et al. Novel Postoperative Strategy for Resectable Pancreatic Cancer. PANCREAS. 2009. 38. 8. 1048-1048
  • M. Sho, I. Yamato, T. Nomi, H. Kanehiro, S. Ko, T. Yamada, T. Akahori, J. Doh, D. Hokuto, Y. Nakajima. Prognostic Significance of CD45Ro+Memory T Cell in Pancreatic Cancer. PANCREAS. 2009. 38. 8. 1048-1048
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page